MedPath

Estimation of a clot end-product called D-Dimer in different stages of pregnancy with establishment of a normal value for Tasmanian women.

Not Applicable
Completed
Conditions
The association of D-Dimer levels with normal pregnancy and also high risk pregnancy, DIC, venous thromboembolic (VTE) and pregnancy loss.
Reproductive Health and Childbirth - Normal pregnancy
Registration Number
ACTRN12609000225213
Lead Sponsor
Assoc Professor Alhossain Khalafallah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
700
Inclusion Criteria

Pregnant women 18 years old and above.

Exclusion Criteria

Age less than 18 years.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The statistical establishment of normal D-dimer levels in each trimester of pregnancy supported by haematological evaluation and well-being questionnaires.[Blood sample once per trimester of pregnancy.]
Secondary Outcome Measures
NameTimeMethod
The seconday outcome will be to determine and evaluate the optimum diagnostic thresholds for D-Dimer levels as predictors of adverse pregnancy outcomes. This will be done by monitoring D-Dimer levels whilst assessing patients for indicators of adverse pregnancy outcomes. This will be acheived through the use of haematological assessment, the use of well-being questionnaires and hospital records of patients' admission for treatment of pathology during pregnancy.[Blood sampled once per trimester in pregnancy, with monthly blood samples from women whose D-Dimer level was higher than the estimated average normal range inpregnancy.]
© Copyright 2025. All Rights Reserved by MedPath